p53 protein expression in meningiomas - A clinicopathologic study of 55 patients

Neurosurgical Review

Volumn 25, Issue 4, 2002, Pages 252-257

  Aguiar, Paulo H ^a   Agner, Celso ^b   Simm, Renata ^a   Freitas, Alexandre B ^a   Tsanaclis, Ana M C ^a   Plese, Jose Pindaro Pereira ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b ALBANY MEDICAL CENTER   (United States)

Author keywords

CNS tumors; Immunohistochemistry; Meningioma; Oncogenes; p53 protein

Indexed keywords

MONOCLONAL ANTIBODY; PROTEIN P53;

ADOLESCENT; ADULT; ARTICLE; BRAIN EDEMA; BRAIN REGION; CANCER GRADING; CLINICAL FEATURE; CORRELATION ANALYSIS; DIAGNOSTIC VALUE; DISEASE CLASSIFICATION; DISEASE SEVERITY; DURA MATER; FEMALE; HEMISPHERE; HISTOPATHOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; MENINGIOMA; NEUROANATOMY; PRIORITY JOURNAL; PROTEIN EXPRESSION; SCHOOL CHILD;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CHILD; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MAGNETIC RESONANCE IMAGING; MALE; MENINGEAL NEOPLASMS; MENINGIOMA; MIDDLE AGED; SEVERITY OF ILLNESS INDEX; STAINING AND LABELING; TOMOGRAPHY, X-RAY COMPUTED; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0036943601     PISSN: 03445607     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10143-002-0204-2     Document Type: Article

References (47)

1. Kleihues P, Cavenee WK (2000) Pathology and genetics tumours of the nervous system. IARC, Lyon, pp 1-314
2. Aguiar PH, Fernandes A, Tsanaclis A (1997) Proliferative growth, p53, and expression of hormonal receptors in meningiomas. Skull Base Surg 7:17
3. Barbareschi M, Iuzzulino P, Penella A, Allegranza A, Arrigoni G, Dalla Palma P, Doglioni C (1992) p53 expression in central nervous system neoplasms. J Clin Pathol 45:583-586
4. Breiman RS, Beck JW, Korobkin M, Glenny R, Akwari OE, Heaston DK, Moore AV, Ram PC (1982) Volume determinators using computed tomography. AJR Am J Roentgenol 138:329-333
5. Bruner JM, Saya H, Moser RP (1991) Immunochemical detection of p53 in human gliomas. Mod Pathol 4:671-674
6. Chung KY, Mukhopadhyay T, Kim J, Casson A, Ro JY, Goepert H, Hong WK, Roth JA (1993) Discordant p53 gene mutations in primary head and neck cancers and corresponding second primary cancers of the upper aerodigestive tract. Cancer Res 53:1676-1683
7. Crone KR, Challa VR, Kute TE, Moody DM, Kelly DL Jr (1988) Relationship between flow cytometric features and clinical behavior of meningiomas. Neurosurgery 23:720-724
8. Dumanski JP, Carlbom E, Collins VP, Nordenskjold M (1987) Deletion mapping of a locus on human chromosome 22 involved in the oncogenesis of meningioma. Proc Natl Acad Sci U S A 84:9275-9279
9. Ellison DW, Gatter KC, Steart PV, Lane DP, Weller RO (1992) Expression of the p53 protein in a spectrum of astrocytic tumours. J Pathol 168:383-386
10. Ellison DW, Lunec J, Gallagher PJ, Steart PV, Jaros E, Gatter KC (1995) Accumulation of wild-type p53 in meningiomas. Neuropathol Appl Neurobiol 21:136-142
11. Figueiredo EG, Aguiar PH, Cordoba BF, Fujimoto Y, Rotta JM, Marino Junior R (1998) Supratentorial meningiomas. Diagnosis, surgical results and complications (in Portuguese). Arq Neuropsiquiatr 56:429-435
12. Fults D, Brockmeyer D, Tullous MW, Pedone CA, Cawthon RM (1992) p53 mutation and loss of heterozygosity on chromosomes 17 and 10 in human astrocytoma progression. Cancer Res 52:674-679
13. Fults D, Tippets RH, Thomas GA, Nakamura Y, White R (1989) Loss of heterozygosity for loci on chromosome 17p in human malignant astrocytoma. Cancer Res 49:6572-577
14. Gilbert JJ, Paulseth JE, Coates RK, Malott D (1983) Cerebral edema associated with meningiomas. Neurosurgery 12:599-605
15. Grzybicki DM, Moore SA (1999) Implications of prognostic markers in brain tumors. Clin Lab Med 19:833-847
16. Hollstein M, Sidransky D, Vogelstein B, Harris CC (1991) p53 Mutations in human cancers. Science 253:49-53
17. Ide M, Jimbo M, Kubo O, Yamamoto M, Imanaga H (1992) Peritumoral brain edema associated with meningioma - histological study of the tumor margin and surrounding brain. Neurol Med Chir (Tokyo) 32:65-71
18. Ide M, Jimbo M, Kubo O, Yamamoto M, Takeyama E, Imanaga H (1994) Peritumoral brain edema and cortical damage by meningioma. Acta Neurochir Suppl (Wien) 60:369-372
19. Ide M, Jimbo M, Yamamoto M, Umebara Y, Hagiwara S, Kubo O (1996) MIB-1 staining index and peritumoral brain edema of meningiomas. Cancer 78:133-143
20. Jaaskelainen J (1985) The growth rate of intracranial meningiomas and its relation to histology. An analysis of 43 patients. Surg Neurol 24:165-172
21. James CD, Carlbom E, Nordenskjold M, Collins VP, Cavenee WK (1989) Mitotic recombination of chromosome 17 in astrocytomas. Proc Natl Acad Sci U S A 86:2858-2862
22. Jaros E, Perry RH, Adam L, Kelly PJ, Crawford PJ, Kalbag RM, Mendelow AD, Sengupta RP, Pearson AD (1992) Prognostic implications of p53 protein, epidermal growth factor receptor, and Ki-67 labeling of brain tumours. Br J Cancer 66:373-385
23. Kallio M, Sankila R, Hakulinen T, Jaaskelainen J (1992) Factors affecting operative and excess long-term mortality in 935 patients with intracranial meningioma. Neurosurgery 31:2-12
24. Karamitopoulou E, Perentes E, Diamantis I (1993) p53 protein expression in central nervous system tumors: an immunohistochemical study with CM1 polyvalent and DO-7 monoclonal antibodies. Acta Neuropathol (Berl) 85:611-616
25. Karamitopoulou E, Perentes E, Diamantis I, Maraziotis T (1983) Ki-67 immunoreactivity in human central nervous system tumors: a study with MIB-1 monoclonal antibody on archival material. Acta Neuropathol (Berl) 87:47-54
26. Karamitopoulou E, Perentes E, Tolnay M, Probst A (1998) Prognostic significance of MIB-1, p53, and bcl-2 immunoreactivity in meningiomas. Hum Pathol 29:140-145
27. Lane DP (1992) Cancer: p53, guardian of the genome. Nature 358:15-16
28. Lane DP (1993) Cancer: a death in the life of p53. Nature 362:786-787
29. Lane DP, Benchimol S (1990) p53: oncogene or anti-oncogene? Genes Dev 4:1-8
30. Levine AJ (1991) The p53 tumour suppressor gene. Nature 351:453-456
31. Levine AJ (1992) The p53 tumour-suppressor gene. N Engl J Med 326:1350-1352
32. Louis DN, von Deimling A, Chung RY, Rubio MP, Whaley JM, Eibl RH, Ohgaki H, Wiestler OD, Thor AD, Seizinger BR (1993) Comparative study of p53 gene and protein alterations in human astrocytic tumors. J Neuropathol Exp Neurol 52:31-38
33. Mashiyama S, Murakami Y, Yoshimoto T, Sekiya T, Hayashi K (1991) Detection of p53 gene mutations in human brain tumors by single-strand conformation polymorphism analysis of polymerase chain reaction products. Oncogene 6:1313-1318
34. Matsuno A, Nagashima T, Matsuura R, Tanaka H, Hirakawa M, Murakami M, Tamura A, Kirino T (1996) Correlation between MIB-1 staining index and the immunoreactivity of p53 protein in recurrent and non-recurrent meningiomas. Am J Clin Pathol 106:776-781
35. Miyagami M, Kanou T, Nakamura S (1996) P53 protein expression and proliferative potential in non-recurrent and recurrent meningiomas (in Japanese). No To Shinkei 48:719-725
36. Nagashima G, Aoyagi M, Wakimoto H, Tamaki M, Ohno K, Hirakawa K (1995) Immunohistochemical detection of progesterone receptors and the correlation with Ki-67 labeling indices in paraffin-embedded sections of meningiomas. Neurosurgery 37:478-482
37. Nagashima G, Aoyagi M, Yamamoto M, Yamamoto S, Wakimoto H, Ohno K, Yamamoto K, Hirakawa K (1999) P53 overexpression and proliferative potential in malignant meningiomas. Acta Neurochir (Wien) 141:53-61
38. Nakasu S, Nakajima M, Matsumura K, Nakasu Y, Handa J (1995) Meningioma: proliferating potential and clinicoradiological features. Neurosurgery 37:1049-1055
39. Ohgaki H, Eibl RH, Schwab M, Reichel MB, Mariani L, Gehring M, Petersen I, Holl T, Wiestler OD, Kleihues P (1993) Mutations of the p53 tumor suppressor gene in neoplasms of the human nervous system. Mol Carcinog 8:74-80
40. Ohkoudo M, Sawa H, Hara M, Saruta K, Aiso T, Ohki R, Yamamoto H, Maemura E, Shiina Y, Fujii M, Saito I (1998) Expression of p53, MDM 2 protein and Ki-67 antigen in recurrent meningiomas. J Neurooncol 38:41-49
41. Perry A, Scheithauer BW, Nascimento AG (1997) The immunophenotypic spectrum of meningeal hemangiopericytoma: a comparison with fibrous meningioma and solitary fibrous tumor of meninges. Am J Surg Pathol 21:1354-1360
42. Perry A, Stafford SL, Scheithauer BW, Suman VJ, Lohse CM (1998) The prognostic significance of MIB-1, p53, and DNA flow cytometry in completely resected primary meningiomas. Cancer 82:2262-2269
43. Prayson RA (1996) Malignant meningioma: a clinicopathologic study of 23 patients including MIB 1 and p53 immunohistochemistry. Am J Clin Pathol 105:719-726
44. Simpson D (1957) The recurrence of intracranial meningiomas after surgical treatment. J Neurol Neurosurg Psychiatry 20:22-39
45. Stevens JM, Ruiz JS, Kendall BE (1983) Observation on peritumoural oedema in meningioma. Part I: Distribution, spread and resolution of vasogenic oedema seen on computed tomography. Neuroradiology 25:71-80
46. Trofatter JA, MacCollin MM, Rutter JL, Murrell JR, Duyao MP, Parry DM, Eldridge R, Kley N, Menon AG, Pulaski K (1993) A novel moesin-, exsin-, radixin-like gene is a candidate for the neurofibromatosis 2 tumor suppressor. Cell 75:826
47. Wang JL, Nister M, Hermansson M, Westermark B, Ponten J (1990) Expression of PDGF beta-receptors in human meningioma cells. Int J Cancer 46:772-778